# THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein

> **NCT05194423** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 150 (estimated)

## Conditions studied

- Tricuspid Valve Regurgitation

## Interventions

- **DEVICE:** Tricuspid Valve Replacement System via jugular vein

## Key facts

- **NCT ID:** NCT05194423
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-01
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2022-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05194423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05194423, "THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05194423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*